Anti-MRSA Cephems: An Update
Current Medicinal Chemistry -Anti-Infective Agents · 2002
DOI: 10.2174/1568012023354929 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Medicinal Chemistry -Anti-Infective Agents, 2002. Verfasst von Dane Springer. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
A review of recent developments in the field of anti-MRSA cephems is presented. The R.W. Johnson / Microcide collaboration seems to be the most advanced effort to date, but many other companies are continuing their efforts to develop a cephalosporin for use against serious Gram-positive infections such as MRSA. A detailed account of the progression of the MRSA cephem program at Bristol-Myers Squibb is provided. This work produced a number of compounds that had excellent biological activity, and were safe in a murine model of acute toxicity. Keywords: anti-mrsa cephem, mrsa cephem
Zitieren
APA
Springer, D. (2002). Anti-MRSA Cephems: An Update. Current Medicinal Chemistry -Anti-Infective Agents. https://doi.org/10.2174/1568012023354929
Vancouver
Springer D. Anti-MRSA Cephems: An Update. Current Medicinal Chemistry -Anti-Infective Agents. 2002. doi:10.2174/1568012023354929
BibTeX
@article{Springer2002,
author = {Springer, Dane},
title = {Anti-MRSA Cephems: An Update},
journal = {Current Medicinal Chemistry -Anti-Infective Agents},
year = {2002},
doi = {10.2174/1568012023354929}
}
EUVIMED